RELX PLC
In the published model solve dated 2026-Q2, anchored at $36.61, RELX PLC (RELX) is priced for +5.7% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 24, 2026 from SEC EDGAR filings.
• All four businesses grew in the first half of 2026 on an underlying basis, with Legal up 10%, Risk up 8%, and Scientific, Technical & Medical and Exhibitions each up 6%, and profit grew faster than revenue [Source: RELX H1 2026 results, 23 July 2026]. • The same technology accelerating the Legal division is also the most credible substitute for what Legal and the scientific publishing business sell, which is organized access to a proprietary body of text. • Capital return is running at scale:
Is RELX overvalued? See what's priced in →
445 institutional managers reported holding RELX in 13F filings for the quarter ended 2026-03-31. Together they hold about 5% of the company; the top 10 hold 2%. 59 opened new positions that quarter. Held by Morgan Stanley, Arrowstreet Capital, Goldman Sachs, among others. On the short side, 3.7M shares were sold short as of the 2026-06-15 count, about 0.2% of shares outstanding (1.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
RELX has cut its share count 4.9% over the past five years. It pays a dividend, and has paid one every year in our records (11 and counting), raised 9 years straight. Cash returned over the past three years: $4.29B in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 24, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.